Juping Zhang
Overview
Explore the profile of Juping Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang B, Li G, Wang S, Zheng Y, Zhang J, Pan B, et al.
Cell Death Dis
. 2024 Oct;
15(10):743.
PMID: 39394189
Autophagy-mediated chemoresistance is the core mechanism for therapeutic failure and poor prognosis in breast cancer. Breast cancer chemotherapy resistance is believed to be influenced by tumor-associated macrophages (TAMs), by which...
2.
Zhang J, Kong Q, Zhang J, Guo J
Open Med (Wars)
. 2024 Sep;
19(1):20241023.
PMID: 39247438
Background: Gastric cancer (GC) is a leading cause of cancer-related morbidity and mortality globally. This meta-analysis was conducted to assess the impact of nutritional interventions on clinical outcomes in GC...
3.
Wang S, Li J, Xu S, Wang N, Pan B, Yang B, et al.
J Extracell Vesicles
. 2024 Jul;
13(7):e12493.
PMID: 39051750
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and chemotherapy is the cornerstone treatment for TNBC. Regrettably, emerging findings suggest that chemotherapy facilitates pro-metastatic changes in the...
4.
Chen C, Huang R, Wang N, Zheng Y, Zhou J, Yang B, et al.
Chin J Nat Med
. 2024 Jun;
22(6):501-514.
PMID: 38906598
Prostate cancer (PCa) is the second most common malignancy among men globally. The Fu-Zheng-Yi-Liu (FZYL) Formula has been widely utilized in the treatment of PCa. This study investigates whether the...
5.
Wang F, Zhang J, Liu M
Math Biosci Eng
. 2024 Jun;
21(4):5430-5445.
PMID: 38872542
A new network-based SIR epidemic model with saturated incidence rate and nonlinear recovery rate is proposed. We adopt an edge-compartmental approach to rewrite the system as a degree-edge-mixed model. The...
6.
Wang S, Li J, Hong S, Wang N, Xu S, Yang B, et al.
J Exp Clin Cancer Res
. 2024 Apr;
43(1):121.
PMID: 38654356
Background: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and chemotherapy still serves as the cornerstone treatment functioning by inducing cytotoxic cell death. Notably, emerging evidence...
7.
Zhao Y, Tan H, Zhang J, Zhan D, Yang B, Hong S, et al.
J Nanobiotechnology
. 2024 Mar;
22(1):122.
PMID: 38504208
Endocrine therapy is standard for hormone receptor-positive (HR) breast cancer treatment. However, current strategies targeting estrogen signaling pay little attention to estradiol metabolism in the liver and is usually challenged...
8.
Tan H, Cao K, Zhao Y, Zhong J, Deng D, Pan B, et al.
Small
. 2024 Mar;
20(31):e2310608.
PMID: 38461532
Depression is a significant global health concern that remains inadequately treated due to the limited effectiveness of conventional drug therapies. One potential therapeutic agent, hypericin (HYP), is identified as an...
9.
Zhang J, Wang L, Jin Z
Infect Dis Model
. 2024 Feb;
9(2):437-457.
PMID: 38385020
In this paper, we analyze the global asymptotic behaviors of a mathematical susceptible-infected(SI) age-infection-structured human immunodeficiency virus(HIV) model with heterogeneous transmission. Mathematical analysis shows that the local and global dynamics...
10.
Zhao Y, Tan H, Zhang J, Pan B, Wang N, Chen T, et al.
Int J Nanomedicine
. 2023 Nov;
18:6847-6868.
PMID: 38026523
Lipid-structured vesicles have been applied for drug delivery system for over 50 years. Based on their origin, lipid-structured vesicles are divided into two main categories, namely synthetic lipid vesicles (SLNVEs)...